CLINIZA

Active

Private limited companyfounded 20242 yrs activeHasseltweg 307, 3600 Genk, BelgiumKBO/BCE: BE 1006.941.855

The computed 12-month bankruptcy probability of CLINIZA is 1.6% (moderate). The annual accounts of CLINIZA for fiscal year 2025 show a net loss of 92% of the equity at the start of that year. The 2025 annual accounts show equity of €8k and a net result of €-88k. Its solvency ranks better than 30% of 4610 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Watch Print / PDF

Checked score

Score 2025

28 / 100

Weak

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability3▼-13

Solvency26▼-21

Growth32

Track record82

Bankruptcy probability, 12 months

1.6% Moderate

0%0.5%1.5%4%10%≥ 25%

No publishable credit limit; credit only on tighter terms

Net loss of at least half of total assets or of the equity at the start of the financial year.

Liquidity short (current ratio 0.17 against 0.3 in 2024; short-term debt: 86.2% and cash: 3.6% of total assets), and 98.8% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.

+raises risk○neutral

Young company

A young company has little track record yet and statistically fails more often than an established one.

KBO · incorporation date

Age against the risk zone

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

1.2%

Return on assets

-12.6%

Age of the figures

9 mo

Persistent losses

Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.

NBB · annual accounts 2025

Net result per financial year

2425

2024 to 2025 · latest year €-88k

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 2 filings

Deviation from the deadline

2025

31 d late

2024

31 d late

← before the deadline after the deadline →

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

21-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity

€8k▼ 91.5%

2024 · €96k

2024: €96k

2024 → 2025

Total assets

€696k▲ 60.1%

2024 · €435k

2024: €435k

2024 → 2025

Net result

€-88k▼ 837%

2024 · €-9k

2024: €-9k

2024 → 2025

Working capital

€-498k▼ 110%

2024 · €-237k

2024: €-237k

2024 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20242025Trend

Equity€96k-€8k▼ 91.5%

Operating result€-9k-€-81k▼ 827%

Net result€-9k-€-88k▼ 837%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €81k in 2025 against €9k in 2024; the loss grows.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €695k

85.4%

14.6%

Fixed assets €593k▲ 79.0%

Current assets €101k▼ 0.2%

Equity and liabilities €696k

98.8%

Equity €8k▼ 91.5%

Debt €688k▲ 103%

The debt ratio rises from 78.0% to 98.8%. Equity is lower and debt is higher.

Key figures and ratios

2025 value · change against 2024

EBITDA

€-57k▼

2024 · €-8k

Cash flow

€-64k▼

2024 · €-9k

Solvency

1.2%▼

2024 · 22.0%

Current ratio

0.17▼

2024 · 0.30

Quick ratio

0.07▼

2024 · 0.23

Debt / equity

85.05▲

2024 · 3.54

ROA

-12.6%▼

2024 · -2.1%

Interest coverage

-8.94▲

2024 · -11.89

Debt

€688k▲

2024 · €339k

Debt ≤ 1 year

€600k▲

2024 · €339k

Debt > 1 year

€88k

Income taxes

€297

Staff costs

€236k▲

2024 · €11k

A ratio outside any meaningful range has been withheld (balance sheet total €696k, equity €8k).

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2025 against 2024

Balance sheet Code20242025

Assets

Total assets20/58€435k€696k▲

Formation expenses20€2k€1k▼

Fixed assets21/28€332k€593k▲

Intangible fixed assets21€3k€3k▼

Tangible fixed assets22/27€328k€588k▲

Plant, machinery and equipment23€91k€237k▲

Furniture and vehicles24€59k€62k▲

Other tangible fixed assets26-€289k

Assets under construction and advance payments27€178k-

Financial fixed assets28-€3k

Current assets29/58€102k€101k▼

Stocks and contracts in progress3€23k€61k▲

Stocks30/36€23k€61k▲

Amounts receivable within one year40/41€35k€5k▼

Trade receivables40-€4k

Other amounts receivable41€35k€1k▼

Cash at bank and in hand54/58€38k€25k▼

Deferred charges and accrued income490/1€5k€11k▲

Equity and liabilities

Total equity and liabilities10/49€435k€696k▲

Equity10/15€96k€8k▼

Contributions10/11€105k€105k=

Profit (loss) carried forward14€-9k€-97k▼

Amounts payable17/49€339k€688k▲

Amounts payable after more than one year17-€88k

Financial debts170/4-€88k

Amounts payable within one year42/48€339k€600k▲

Current portion of amounts payable after more than one year42-€15k

Financial debts43-€5k

Credit institutions430/8-€5k

Trade debts44€185k€97k▼

Suppliers440/4€185k€97k▼

Advances received on contracts in progress46-€17k

Taxes, remuneration and social security45€6k€97k▲

Taxes450/3€131€32k▲

Remuneration and social security454/9€6k€65k▲

Other amounts payable47/48€148k€368k▲

Accrued charges and deferred income492/3-€509

Income statement Code20242025

Remuneration, social security and pensions62€11k€236k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€296€24k▲

Other operating charges640/8€387€2k▲

Gross operating margin9900€3k€181k▲

Operating profit (loss)9901€-9k€-81k▼

Financial income75/76B€126€321▲

Recurring financial income75€126€321▲

Financial charges65/66B€712€6k▲

Recurring financial charges65€712€6k▲

Profit (loss) for the period before taxes9903€-9k€-87k▼

Income taxes67/77-€297

Profit (loss) for the period9904€-9k€-88k▼

Profit (loss) for the period to be appropriated9905€-9k€-88k▼

Appropriation of the result

Profit (loss) to be appropriated9906€-9k€-97k▼

Profit (loss) brought forward from the previous period14P-€-9k

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 2Filings 2

Next filing, fiscal year 2026, expected by 31-07-2027

2026

31-08

NBB filing Annual accounts filed

fiscal year 2025 · micro schema · 31 days late

2025

31-08

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 31 days late

NBB filing

Directors · office · real estate

Directors

1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Genk · 1 establishment unit since 2024

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Hasseltweg 3073600 Genk

Ground area

2,476 m²

Building footprint

514 m²

Volume, LiDAR

4,452 m³

Parcel 71306G0215/00R125, Flanders · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.

1 establishment unit

CLINIZA

Hasseltweg 307, 3600 GenkRetail sale of cosmetics and toilet articles

since 20242.358.062.674

1 parcel

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
71306G0215/00R125	Flanders	2,476 m²	1 · 514 m²	11.2 m · 3 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

DERMAL ART

BE 0802.980.351

Wezembeek-Oppem · Eq €8k

Profondeville · Eq €8k

Of 24,863 companies in sector 96220 we hold annual accounts for 1,443. 1,036 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded08-03-2024

Fiscal year end31-12

Activities, NACEBEL

96022Beauty treatment

96220Beauty care and other beauty treatments

47750Retail sale of cosmetics and toilet articles

Sources

Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.